INmune Bio Inc expected to post a loss of 48 cents a share - Earnings Preview

Inmune Bio

28/02/2023 21:22

* INmune Bio Inc  INMB.OQ   INMB.O  is expected to show a
fall in
quarterly revenue when it reports  results on March 2. 
    * 
    * ​Refinitiv's mean analyst estimate for INmune Bio Inc is
for a
loss of 48 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for INmune Bio
Inc is
$18​, above​ its last closing price of $9.31. ​​​

This summary was machine generated February 28 at 21:21 GMT. 
All figures in US dollars  unless otherwise stated